USNA Quote, Financials, Valuation and Earnings

Bridgford Foods Corp. has a net margin of -3.12% compared to USANA Health Sciences, Inc.'s net margin of -3.15%. USANA Health Sciences, Inc.'s return on equity of 3.06% beat Bridgford Foods Corp.'s return on equity of -5.79%.

USANA Health Sciences, Inc. has a consensus price target of $39.00, signalling upside risk potential of 95%. On the other hand Bridgford Foods Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that USANA Health Sciences, Inc. has higher upside potential than Bridgford Foods Corp., analysts believe USANA Health Sciences, Inc. is more attractive than Bridgford Foods Corp..

USANA Health Sciences, Inc. has a beta of 0.655, which suggesting that the stock is 34.453% less volatile than S&P 500. In comparison Bridgford Foods Corp. has a beta of -0.249, suggesting its less volatile than the S&P 500 by 124.925%.

USANA Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bridgford Foods Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. USANA Health Sciences, Inc. pays -- of its earnings as a dividend. Bridgford Foods Corp. pays out -- of its earnings as a dividend.

USANA Health Sciences, Inc. quarterly revenues are $213.7M, which are larger than Bridgford Foods Corp. quarterly revenues of $52M. USANA Health Sciences, Inc.'s net income of -$6.7M is lower than Bridgford Foods Corp.'s net income of -$1.6M. Notably, USANA Health Sciences, Inc.'s price-to-earnings ratio is 22.47x while Bridgford Foods Corp.'s PE ratio is 62.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for USANA Health Sciences, Inc. is 0.41x versus 0.29x for Bridgford Foods Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Healthy Choice Wellness Corp. has a net margin of -3.12% compared to USANA Health Sciences, Inc.'s net margin of -3.52%. USANA Health Sciences, Inc.'s return on equity of 3.06% beat Healthy Choice Wellness Corp.'s return on equity of -43.51%.

USANA Health Sciences, Inc. has a consensus price target of $39.00, signalling upside risk potential of 95%. On the other hand Healthy Choice Wellness Corp. has an analysts' consensus of $2.00 which suggests that it could grow by 538.77%. Given that Healthy Choice Wellness Corp. has higher upside potential than USANA Health Sciences, Inc., analysts believe Healthy Choice Wellness Corp. is more attractive than USANA Health Sciences, Inc..

USANA Health Sciences, Inc. has a beta of 0.655, which suggesting that the stock is 34.453% less volatile than S&P 500. In comparison Healthy Choice Wellness Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

USANA Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthy Choice Wellness Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. USANA Health Sciences, Inc. pays -- of its earnings as a dividend. Healthy Choice Wellness Corp. pays out -- of its earnings as a dividend.

USANA Health Sciences, Inc. quarterly revenues are $213.7M, which are larger than Healthy Choice Wellness Corp. quarterly revenues of $20.3M. USANA Health Sciences, Inc.'s net income of -$6.7M is lower than Healthy Choice Wellness Corp.'s net income of -$712.4K. Notably, USANA Health Sciences, Inc.'s price-to-earnings ratio is 22.47x while Healthy Choice Wellness Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for USANA Health Sciences, Inc. is 0.41x versus 0.05x for Healthy Choice Wellness Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Herbalife Ltd. has a net margin of -3.12% compared to USANA Health Sciences, Inc.'s net margin of 3.38%. USANA Health Sciences, Inc.'s return on equity of 3.06% beat Herbalife Ltd.'s return on equity of --.

USANA Health Sciences, Inc. has a consensus price target of $39.00, signalling upside risk potential of 95%. On the other hand Herbalife Ltd. has an analysts' consensus of $12.00 which suggests that it could fall by -15.37%. Given that USANA Health Sciences, Inc. has higher upside potential than Herbalife Ltd., analysts believe USANA Health Sciences, Inc. is more attractive than Herbalife Ltd..

USANA Health Sciences, Inc. has a beta of 0.655, which suggesting that the stock is 34.453% less volatile than S&P 500. In comparison Herbalife Ltd. has a beta of 0.819, suggesting its less volatile than the S&P 500 by 18.101%.

USANA Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Herbalife Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. USANA Health Sciences, Inc. pays -- of its earnings as a dividend. Herbalife Ltd. pays out -- of its earnings as a dividend.

USANA Health Sciences, Inc. quarterly revenues are $213.7M, which are smaller than Herbalife Ltd. quarterly revenues of $1.3B. USANA Health Sciences, Inc.'s net income of -$6.7M is lower than Herbalife Ltd.'s net income of $43.1M. Notably, USANA Health Sciences, Inc.'s price-to-earnings ratio is 22.47x while Herbalife Ltd.'s PE ratio is 4.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for USANA Health Sciences, Inc. is 0.41x versus 0.29x for Herbalife Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Laird Superfood, Inc. has a net margin of -3.12% compared to USANA Health Sciences, Inc.'s net margin of -7.56%. USANA Health Sciences, Inc.'s return on equity of 3.06% beat Laird Superfood, Inc.'s return on equity of -14.38%.

USANA Health Sciences, Inc. has a consensus price target of $39.00, signalling upside risk potential of 95%. On the other hand Laird Superfood, Inc. has an analysts' consensus of $7.67 which suggests that it could grow by 234.79%. Given that Laird Superfood, Inc. has higher upside potential than USANA Health Sciences, Inc., analysts believe Laird Superfood, Inc. is more attractive than USANA Health Sciences, Inc..

USANA Health Sciences, Inc. has a beta of 0.655, which suggesting that the stock is 34.453% less volatile than S&P 500. In comparison Laird Superfood, Inc. has a beta of 2.351, suggesting its more volatile than the S&P 500 by 135.079%.

USANA Health Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Laird Superfood, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. USANA Health Sciences, Inc. pays -- of its earnings as a dividend. Laird Superfood, Inc. pays out -- of its earnings as a dividend.

USANA Health Sciences, Inc. quarterly revenues are $213.7M, which are larger than Laird Superfood, Inc. quarterly revenues of $12.9M. USANA Health Sciences, Inc.'s net income of -$6.7M is lower than Laird Superfood, Inc.'s net income of -$975.1K. Notably, USANA Health Sciences, Inc.'s price-to-earnings ratio is 22.47x while Laird Superfood, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for USANA Health Sciences, Inc. is 0.41x versus 0.50x for Laird Superfood, Inc.. Usually stocks with elevated PS ratios are considered overvalued.